FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions BPC 157 and Female Fertility: Effects, Mechanisms, Safety and Risks FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post